e-learning
resources
Virtual 2021
07.09.2021
COVID - 19 risk predictions
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Association between type of antihyperglycemic therapy and COVID-19 outcomes in patients with type 2 DM
L. Akulkina (Moscow, Russian Federation), A. Schepalina (Moscow, Russian Federation), V. Sholomova (Moscow, Russian Federation), M. Brovko (Moscow, Russian Federation), S. Moiseev (Moscow, Russian Federation), A. Yanakaewa (Moscow, Russian Federation), D. Konovalov (Moscow, Russian Federation)
Source:
Virtual Congress 2021 – COVID - 19 risk predictions
Session:
COVID - 19 risk predictions
Session type:
E-poster
Number:
3653
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Akulkina (Moscow, Russian Federation), A. Schepalina (Moscow, Russian Federation), V. Sholomova (Moscow, Russian Federation), M. Brovko (Moscow, Russian Federation), S. Moiseev (Moscow, Russian Federation), A. Yanakaewa (Moscow, Russian Federation), D. Konovalov (Moscow, Russian Federation). Association between type of antihyperglycemic therapy and COVID-19 outcomes in patients with type 2 DM. 3653
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Association between type 2 diabetes and respiratory symptoms
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Death rate of COPD patients and combination with type 2 diabetes
Source: Eur Respir J 2007; 30: Suppl. 51, 79s
Year: 2007
Relative risk of type 2 diabetes mellitus complications is increased in non effectively treated OSA patients
Source: Eur Respir J 2005; 26: Suppl. 49, 39s
Year: 2005
A study of the comorbidity of COPD and type 2 diabetes mellitus
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Association between bronchial reactivity and diabetes type 2
Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes
Year: 2019
Insulin therapy increases airway responsiveness in type 2 diabetes patients
Source: Annual Congress 2008 - Cough and airway hyperresponsiveness
Year: 2008
Is there any characteristics difference between pulmonary tuberculosis patients with and without diabetes mellitus type 2?
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009
Effectiveness of mesodiencephalic modulation in treatment of XDR TB patients with concomitant type II diabetes mellitus
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
COPD prevalence and severity is associated to type 2 diabetes mellitus complications and lack of glycometabolic control
Source: Annual Congress 2008 - COPD and comorbidities
Year: 2008
The conjunctival microcirculation disturbances at COPD patients in combination with diabetes mellitus type 2 and their correction by gliclazide
Source: Eur Respir J 2004; 24: Suppl. 48, 61s
Year: 2004
Effect of roflumilast (ROF) on glucose levels in patients with COPD and diabetes mellitus type 2 (DM2)
Source: Annual Congress 2010 - COPD: management
Year: 2010
Mesodiencephalic modulation in the treatment of XDR TB patients with concomitant type II diabetes mellitus
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021
Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012
Study of PFT‘s in patients with type 2 diabetes mellitus and diabetic neuropathy and microangiopathy
Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases
Year: 2007
Safety profile of COPD medications in COPD patients with concomitant diabetes mellitus
Source: International Congress 2017 – COPD management
Year: 2017
Association between continuous positive airway pressure, weight change and glycaemic control in patients with type 2 diabetes
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020
Association between type 2 diabetes, prediabetes and lung function: Results from the KORA cohort
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018
Respiratory muscle function in type 2 diabetes mellitus
Source: Annual Congress 2008 - Assessment of the respiratory system
Year: 2008
Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma
Source: Eur Respir J, 58 (4) 2004605; 10.1183/13993003.04605-2020
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept